Operating Lease, Right-of-Use Asset of Pacira BioSciences, Inc. from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Pacira BioSciences, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • Pacira BioSciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $41,777,000, a 15% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Pacira BioSciences, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $41,777,000 -$7,445,000 -15% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $44,266,000 -$9,564,000 -18% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $46,528,000 -$9,736,000 -17% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $48,728,000 -$9,898,000 -17% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $49,222,000 -$11,798,000 -19% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $53,830,000 -$9,564,000 -15% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $56,264,000 -$9,573,000 -15% 30 Jun 2024 10-Q 30 Jul 2024 2024 Q2
Q1 2024 $58,626,000 -$9,458,000 -14% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $61,020,000 -$9,857,000 -14% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $63,394,000 -$6,268,000 -9% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $65,837,000 -$6,245,000 -8.7% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 $68,084,000 -$6,187,000 -8.3% 31 Mar 2023 10-Q 03 May 2023 2023 Q1
Q4 2022 $70,877,000 -$5,533,000 -7.2% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 $69,662,000 -$128,000 -0.18% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $72,082,000 +$830,000 +1.2% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 $74,271,000 +$1,383,000 +1.9% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $76,410,000 +$1,918,000 +2.6% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $69,790,000 -$6,257,000 -8.2% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $71,252,000 -$6,547,000 -8.4% 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 $72,888,000 +$35,275,000 +94% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 $74,492,000 +$36,368,000 +95% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 $76,047,000 +$40,291,000 +113% 30 Sep 2020 10-Q 30 Oct 2020 2020 Q3
Q2 2020 $77,799,000 +$41,305,000 +113% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $37,613,000 +$10,927,000 +41% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $38,124,000 +$38,124,000 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 $35,756,000 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 $36,494,000 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 $26,686,000 31 Mar 2019 10-Q 02 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-K 21 Feb 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.